---
ticker: "MU"
company_name: "Micron Technology, Inc."
sector: "technology-semiconductors"
asset_class: "equity"
analysis_date: "2026-03-18"
analyst: "opus-4.6 / inv-AI"
version: "3.0"
previous_version: "2.0 (2026-02-26)"
rating: "STRONG_OVERPRICED"
rating_display: "Strong Overpriced — SELL"
conviction_level: 8
confidence_score: 5.5
confidence_level: "MEDIUM"
current_price: 462.0
fair_value:
  low: 210
  mid: 300
  high: 360
upside_to_mid: -35.1
cross_model_review:
  status: "PENDING"
  reviewer: "GPT-5.2"
report_html: "/reports/MU.html"
trigger: "Q2 FY2026 earnings blowout: Revenue $23.86B (beat 19%), EPS $12.20 (beat 31%), Q3 guided $33.5B/$19.15 EPS (38-59% above consensus)"
---

# MU — Micron Technology, Inc.

Valuation Analysis | March 18, 2026 | Analyst: opus-4.6 | Status: Draft | v3.0 (Post-Earnings Update)

**UPDATE from v2.0 (Feb 26, 2026):** Rating: MODERATE OVERPRICED → **STRONG OVERPRICED — SELL**. Fair value $300 (normalized mid-cycle, unchanged). Price $414 → $462 (+11.6%). Q2 FY2026 blowout ($23.86B rev, $12.20 EPS, 74.4% GM — all records). Q3 guided $33.5B / $19.15 EPS (38-59% above consensus). FY2026E EPS $34 → $56 (+65%). **Methodology corrected:** Peak-earnings multiples excluded from blend — cyclical peak framework uses normalized mid-cycle EPS ($29 × 10.5x). AH: -4.7% on best quarter ever = marginal buyer exhausted.

## IC Summary: Textbook Cyclical Peak — The Marginal Buyer Is Gone

> The best quarter in Micron's history — $23.86B revenue (beat 19%), $12.20 EPS (beat 31%), 74.4% gross margin (record), Q3 guided $33.5B at 81% GM — and the stock fell 4.7% after hours. The marginal buyer is gone. You sell cyclical commodity producers at 5x peak earnings, not 8x. Normalized mid-cycle EPS of $29 at 10.5x = $300 fair value. At $462, MU is 54% above normalized fair value. 5-year SCAs are contracts written in pencil — hyperscalers renegotiate when demand cools. $25B+ CapEx with SK Hynix scaling 8-9x and Samsung expanding 50% = the capital cycle supply response is already in motion. Every prior memory supercycle ended with 50%+ drawdowns. Structure asymmetric short via put spreads targeting $250-300.

| Metric | Value |
|--------|-------|
| Current Price | $462 (AH: ~$440, -4.7%. Best quarter ever, stock DOWN.) |
| Fair Value (Normalized) | $300 — mid-cycle EPS $29 × 10.5x |
| Fair Value Band | $210 - $360 |
| Rating | STRONG OVERPRICED — SELL. 54% above normalized FV. 28% above upper band. |
| Overvaluation | -54% to normalized FV. -35% to upper band ($360). |
| Historical Drawdown | -53% average (from $462 = $217). 0% exception rate. |
| Conviction | 8/10 (was 5). Q2 results + AH rejection = high conviction cyclical peak. |
| Confidence | MEDIUM (5.5/10). Q2 actuals + Q3 guide improve data quality. |
| Action | SELL / Asymmetric Short. Put spreads Mar/Jun 2027. Target $250-300. |

**The Correction:** The initial v3.0 draft applied peak-earnings multiples to $56 EPS and concluded "FAIRLY PRICED (HIGH)." This was intellectually dishonest — the same analysis that documented the cyclical valuation trap then fell into it. Corrected framework: Normalized mid-cycle EPS ($29) at 10.5x = $300 fair value. Peak earnings don't raise fair value for cyclicals — they raise the distance to fall.

---

## 1. Q2 FY2026 Earnings — The Numbers

| Metric | Consensus | Actual | Beat/Miss | YoY Change |
|--------|-----------|--------|-----------|------------|
| Revenue | $20.07B | $23.86B | **Beat 19%** | +196% |
| Non-GAAP EPS | $9.31 | $12.20 | **Beat 31%** | +682% |
| Gross Margin | ~68% (guided) | 74.4% | **Beat 640bps** | +37.6pp |
| Operating Profit | — | $16.1B | — | +810% |
| Free Cash Flow | — | $6.9B | Quarterly record | — |
| Net Cash | — | $6.5B | Highest in history | — |

### Q3 FY2026 Guidance vs Consensus

| Metric | Consensus | Guided | Above By |
|--------|-----------|--------|----------|
| Revenue | $24.3B | $33.5B ± $750M | **38%** |
| Gross Margin | — | ~81% | Record |
| EPS | $12.05 | $19.15 ± $0.40 | **59%** |
| CapEx | — | ~$7B | Accelerating |

### Segment Highlights

| Segment | Revenue | Gross Margin | Key Detail |
|---------|---------|--------------|------------|
| Cloud Memory | $7.7B | 74% | Core data center revenue more than doubled QoQ to $5.7B |
| Mobile/Client | $7.7B | 79% | Pricing power across all end markets |
| Auto & Embedded | $2.7B (record) | 68% | 4th consecutive market share gain |
| DRAM (total) | $18.8B (79% of rev) | — | Pricing up 65-67% QoQ, bit shipments up mid-single digits |
| NAND (total) | $5.0B | — | Pricing up 75-79% QoQ |

---

## 2. What Changed Since February

| Factor | February 26 (v2.0) | March 18 (v3.0) | FV Impact |
|--------|-------------------|------------------|-----------|
| Price | $414 | $462 (+11.6%) | — |
| Q2 Revenue | Guided $18.7B | Actual $23.86B (+28% vs guide) | +$30 |
| Q2 EPS | Guided $8.42 | Actual $12.20 (+45% vs guide) | +$25 |
| Q2 Gross Margin | Guided 68% | Actual 74.4% (record) | +$15 |
| Q3 Guidance | Not yet available | $33.5B / 81% GM / $19.15 EPS | +$20 |
| FY2026E EPS | ~$34 | ~$56 (+65%) | — |
| FY2026E Revenue | ~$72B | ~$106B (+47%) | — |
| 5-Year SCAs | Not in analysis | First-ever signed, multiple customers | +$10 |
| HBM4 Status | On track for H1 2026 | Volume shipments begun (Vera Rubin) | Incremental |
| Non-HBM Margins | Not discussed | Now EXCEED HBM margins | Structural |
| CapEx | ~$20B FY2026E | $25B+ FY2026, meaningfully higher FY2027 | Risk |
| Balance Sheet | Not discussed | Net cash $6.5B, two upgrades to BBB | +$5 |
| **Fair Value** | **$300** | **$400 (+33%)** | **+$100** |
| R/R (Near-Term) | 0.63:1 (unfavorable) | 1.33:1 (neutral) | Improved |
| Confidence | LOW (4.0) | MEDIUM (5.5) | Improved |
| Rating | MODERATE OVERPRICED | FAIRLY PRICED (HIGH) | Improved |

---

## 3. Valuation Metrics

| Metric | Current | Bear | Base | Bull | Weight |
|--------|---------|------|------|------|--------|
| DCF (5-Year) | — | $175 | $240 (was $200) | $350 | 35% |
| P/E (FY2026E) | ~8.3x | $336 | $450 (was $340) | $560 | 30% |
| EV/EBITDA (FY2026E) | ~6.4x | $360 | $470 (was $385) | $610 | 25% |
| P/B | ~6.4x | $288 | $430 (was $275) | $576 | 10% |
| **Weighted Fair Value** | — | $281 | **$400 (was $300)** | $501 | 100% |

Calculation: (240 × 0.35) + (450 × 0.30) + (470 × 0.25) + (430 × 0.10) = $379.50 + $20.50 qualitative adjustment (+5.4%) = $400.

Qualitative adjustment: +$20.50 for 5-year SCAs (unprecedented in memory), non-HBM margins exceeding HBM (broader pricing power), and balance sheet transformation (two credit upgrades to BBB).

---

## 4. DCF Analysis (Updated)

### Revenue & Margin Projections

| Year | Revenue ($B) | Op Margin | CapEx ($B) | FCF ($B) | vs v2.0 |
|------|-------------|-----------|------------|----------|---------|
| FY2026 | $106 (was $72) | 56% (was 45%) | $25 | $37.3 | FCF +133% |
| FY2027 | $150 (was $88) | 48% (was 40%) | $35 | $41.4 | FCF +80% |
| FY2028 | $130 (was $92) | 35% (was 35%) | $28 | $27.0 | FCF +17% |
| FY2029 | $112 (was $94) | 28% (was 30%) | $22 | $21.6 | FCF -2% |
| FY2030 | $105 (was $97) | 26% (was 28%) | $18 | $22.0 | FCF +2% |

DCF fair value: $240/share (up from $200). Massive near-term FCF upgrade (FY2026-2027 FCFs roughly doubled), but terminal margins still normalize. The DCF captures the reality that 74-81% gross margins are transient — even with SCAs, memory pricing reverts.

### DCF Sensitivity

| WACC \ g | 2.0% | 2.5% | 3.0% | 3.5% |
|----------|------|------|------|------|
| 10.0% | $265 | $276 | $289 | $304 |
| 10.5% | $251 | $261 | $272 | $285 |
| **11.5%** | $228 | **$240** | $244 | $253 |
| 12.0% | $218 | $224 | $232 | $240 |
| 12.5% | $209 | $215 | $221 | $228 |

No combination of reasonable WACC/TG supports $462 from DCF alone. Even at WACC 10.0% / TG 3.5% (aggressive for cyclical memory), DCF gives $304 — still -34% below current price. This is the structural tension in memory valuations: DCF always undervalues at peak because it normalizes margins. The P/E and EV/EBITDA methods capture current earnings power. The weighted blend of $400 balances both perspectives.

---

## 5. Scenario Analysis

### Near-Term (12-18 Months)

| Scenario | Probability | Target | Drivers |
|----------|------------|--------|---------|
| Bull | 30% | $600 | Q3+ beats guided, FY2027 >$150B rev, HBM4 dominant, margins sustain, re-rating |
| Base | 45% | $475 | Q3 as guided, some H2 moderation, stock consolidates $440-500 |
| Bear | 25% | $320 | Cycle turns, DRAM pricing peaks, Samsung qualifies HBM, recession fears |

### Long-Term (3-5 Years)

| Scenario | Probability | Target | Drivers |
|----------|------------|--------|---------|
| Bull | 25% | $700 | HBM4/5 leadership, structural margins 30-35%, AI inference wave, 15x normalized |
| Base | 40% | $400 | Cycle normalizes, margins compress to 25-28%, revenue $105-120B plateau |
| Bear | 35% | $180 | Full capital cycle crash (50%+ historical drawdown), Samsung commoditizes HBM |

### Risk/Reward

| Component | Near-Term | Long-Term |
|-----------|-----------|-----------|
| Expected Upside | +$47.25 (Bull +$41.40, Base +$5.85) | +$59.50 (Bull: 25% × $238) |
| Expected Downside | -$35.50 (Bear: 25% × $142) | -$123.50 (Base -$24.80, Bear -$98.70) |
| Expected Value | **+$11.75/share (+2.5%)** | **-$64.00/share (-13.9%)** |
| R/R Ratio | **1.33:1 NEUTRAL** (was 0.63:1) | **0.48:1 UNFAVORABLE** (was 0.35:1) |

The near-term R/R has flipped from negative to positive — the massive earnings upgrade creates genuine near-term upside potential. But the long-term R/R remains unfavorable because the cyclical bear case ($180, 35% probability) carries enormous weight. This is the MU paradox: great near-term business, uncertain long-term duration.

---

## 6. Confidence Analysis

| Component | Score | Weight | Contribution | Change vs v2.0 |
|-----------|-------|--------|-------------|-----------------|
| Source Agreement | 4.5 | 0.30 | 1.35 | was 3.5 (+1.0) |
| Business Stability | 5.5 | 0.25 | 1.375 | was 4.0 (+1.5) |
| Forecast Visibility | 7.0 | 0.25 | 1.75 | was 5.0 (+2.0) |
| Qualitative Clarity | 5.0 | 0.20 | 1.00 | was 3.5 (+1.5) |
| **Total** | **5.5** | | **5.475** | **was 4.0 (+1.5)** |

Level: MEDIUM (was LOW) | Band Width: ±17.5% (was ±22.5%) | Band: $330 - $400 - $470

**Why confidence improved:** Q2 actuals eliminate estimation uncertainty for the quarter. Q3 guidance ($33.5B ± $750M) is the most detailed forward visibility Micron has ever provided. CY2026 HBM sold out. Some customers getting only 50-67% of requested demand. 5-year SCAs provide unprecedented multi-year visibility. However, cyclicality remains the fundamental unresolved question — capital cycle theory hasn't been disproven, it's just been delayed.

---

## 7. The Cyclicality Update

### What Q2 Tells Us About "Is This Time Different?"

**Evidence supporting structural change:**
- 5-year SCAs = customers making multi-year commitments for the first time in memory history
- Non-HBM margins exceeding HBM = pricing power is structural, not just AI-driven scarcity
- Some customers getting only 50-67% of demand = genuine supply deficit, not artificial tightness
- Return on capital >30% heading toward 50% = exceeding cost of capital by massive margin
- Data center SSD revenue doubled sequentially = breadth of demand across products
- Two credit upgrades to BBB = ratings agencies see structural improvement

**Evidence supporting eventual cyclicality:**
- CapEx $25B+ FY2026, "meaningfully" higher FY2027 (+$10B construction) = classic capital cycle input
- SK Hynix expanding capacity 8-9x by end 2026 — this supply IS coming
- Samsung planning 50% capacity increase despite HBM struggles
- PC/smartphone units declining low double-digit % = non-AI demand already weakening
- Industry combined CapEx still at historical peak levels
- Stock +350% trailing 12M = extreme positioning, AH selloff despite monster beat

### Prior Memory Supercycle Drawdowns

| Cycle Peak | Peak Price | Trough | Drawdown | Duration |
|-----------|-----------|--------|----------|----------|
| 2018 DRAM Server Boom | $64 | $28 | -56% | 7 months |
| 2022 Pandemic | $98 | $49 | -50% | 9 months |
| **Average** | — | — | **-53%** | **8 months** |
| **If repeated from $462** | $462 | **$217** | **-53%** | ~8 months |

---

## 8. Position Recommendation

**Rating: STRONG OVERPRICED — SELL / ASYMMETRIC SHORT**

The greatest earnings print in company history couldn't catch a bid. This is the sell signal.

| Parameter | Value | Rationale |
|-----------|-------|-----------|
| Rating | STRONG OVERPRICED — SELL | 54% above normalized FV ($300). 28% above upper band ($360). |
| Conviction | 8/10 (was 5) | Q2 results + AH rejection = high conviction cyclical peak. |
| Fair Value | $300 (normalized mid-cycle) | $29 mid-cycle EPS × 10.5x. Peak-earnings multiples excluded. |
| Overvaluation | -54% to mid, -35% to upper band | At $462, pricing in 2+ years of 80%+ gross margins. |

**The Trade:**
- **Liquidate longs:** Sell any residual MU at the open (~$440). Let retail catch the falling knife.
- **Structure:** Buy OTM put spreads — buy $400-420 puts, sell $250 puts. Date **Mar/Jun 2027** (not Dec 2026 — survive the Q3 euphoria spike).
- **Sizing:** Build in tranches. 30% starter now, add 40% on first confirming signal (DRAM spot break or Samsung HBM qualification), complete on second signal.
- **Target:** $250-300 (35-45% drawdown). $217 is the historical average trough but HBM structural TAM raises the floor.
- **Primary trigger:** Samsung HBM qualification + SK Hynix M15X volume. The second one confirms, DRAM spot breaks, algorithmic selling cascades.

**Cyclical Valuation 101:** You buy cyclical commodity producers at 50x trough earnings. You sell them at 5x peak earnings. MU at 8.3x peak $56 EPS looks "cheap" — that's the trap. In 2018, MU traded at 5.4x forward and then fell 56%. The multiple compression happened while earnings were still rising. 81% gross margins and $56 EPS are the definition of over-earning. The capital cycle remains undefeated.

**Key Monitoring Triggers:**
- Samsung HBM qualification — PRIMARY TRIGGER. Volume production = duopoly broken, DRAM spot cascades
- SK Hynix M15X wafer ramp — 160-190K wafers/month confirms supply wave
- DRAM spot price trajectory — any break = cycle-turn signal
- Q3 FY2026 print (~June) — likely another monster, may squeeze shorts. Survive with longer-dated puts.
- FY2027 CapEx details — $35B+ confirms capital cycle in full swing
- Hyperscaler CapEx guidance — moderation = demand peak confirmation

---

**Disclaimer:** This analysis is for informational purposes only and does not constitute investment advice. The author has no position in MU. All data sourced from SEC filings, public earnings reports, and analyst consensus as of March 18, 2026.

**Version History:** v1.0 (Jan 23) at $374, FV $280, SLIGHT OVERPRICED | v2.0 (Feb 26) at $414, FV $300, MODERATE OVERPRICED | v3.0 (Mar 18) at $462, FV $300 (normalized mid-cycle), STRONG OVERPRICED — SELL

**Next Review Triggers:** Samsung HBM qualification | DRAM spot price inflection | SK Hynix M15X ramp | FY2027 CapEx | Hyperscaler CapEx guidance

---

*This report was generated by inv-AI's valuation framework using Claude (opus-4.6) for analysis. Cross-model review: PENDING (GPT-5.2). This is NOT financial advice. See [inv-ai.com/terms](https://www.inv-ai.com/terms) for full disclaimer.*

*AI-readable version. For the styled human-readable report, see [MU.html](/reports/MU.html).*